New combination treatment offers hope for older patients with mantle cell lymphoma
The phase 2 trial PrE0405 met its primary endpoint, achieving a complete response (CR) rate of 85% in 33 patients ...
Tag: Rituximab
Rheumatoid arthritis drug can reduce the risk of deterioration in myasthenia gravis
Early intervention with rituximab, a drug used in the treatment of rheumatoid arthritis (RA), can reduce the risk of deterioration ...
Risk of severe COVID-19 in adults with immune-mediated inflammatory diseases and those on immune-modifying therapies
In a recent study published in The Lancet Rheumatology, researchers assessed the risk of severe coronavirus disease 2019 (COVID-19) in ...
Molecular profiling of diseased joints could transform treatment for rheumatoid arthritis patients
New analysis from Queen Mary College of London, printed in Nature Drugs, has proven that molecular profiling of the diseased ...
